Revenue
2022
2023
2024
2025
Arecor Therapeutics plc (AREC)
Price£0.7650Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £1.7M | £1.6M | £4.6M | £2.4M |
| Research & development | £2.7M | £3.0M | £5.4M | £8.6M |
| Operating expenses | £5.3M | £6.1M | £10.4M | £12.9M |
| Operating income | −£4.0M | −£5.2M | −£9.2M | −£10.5M |
| Operating margin | −236.00% | −315.03% | −200.63% | −437.45% |
| EBITDA | £1.2M | −£4.7M | −£8.4M | −£10.1M |
| EBITDA margin | 71.18% | −287.28% | −183.47% | −418.73% |
| Net income | £664,000 | −£10.2M | −£8.6M | −£9.3M |
| Net profit margin | 38.74% | −623.01% | −187.05% | −385.35% |
| Basic EPSper basic share | £0.02 | -£0.31 | -£0.00 | -£0.32 |
| Diluted EPSper diluted share | £0.02 | -£0.31 | -£0.00 | -£0.32 |